Concord Medical Co., Ltd. (TPEX:6518)

Taiwan · Delayed Price · Currency is TWD

31.55

+1.30 (4.30%)

Aug 19, 2026, 1:50 PM CST

17.94% (1Y)

Market Cap	1.02B +14.4%
Revenue (ttm)	1.04B +14.7%
Net Income	85.79M +56.7%
EPS	2.55 +55.4%
Shares Out	33.33M
PE Ratio	12.01
Forward PE	n/a
Dividend	1.50 (4.96%)
Ex-Dividend Date	Apr 10, 2026

Volume	1,010
Open	31.55
Previous Close	30.25
Day's Range	31.55 - 31.55
52-Week Range	25.50 - 53.60
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Concord Medical

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment pl... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2009

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 6518

Full Company Profile

Financial Performance

In 2025, Concord Medical's revenue was 964.35 million, an increase of 8.37% compared to the previous year's 889.85 million. Earnings were 67.36 million, an increase of 35.90%.

Financial Statements